批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/08/11 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:HYDROCHLOROTHIAZIDE; VALSARTAN 剂型/给药途径:TABLET;ORAL 规格:12.5MG;80MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020818 |
001 |
NDA |
DIOVAN HCT |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;80MG |
Prescription |
Yes |
No |
AB |
1998/03/06
|
NOVARTIS |
078020 |
001 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;80MG |
Prescription |
No |
No |
AB |
2012/09/21
|
MYLAN PHARMS INC |
078946 |
003 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;80MG |
Prescription |
No |
No |
AB |
2013/03/21
|
LUPIN LTD |
201662 |
001 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;80MG |
Prescription |
No |
No |
AB |
2013/03/21
|
ALEMBIC |
202519 |
001 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;80MG |
Prescription |
No |
No |
AB |
2013/03/21
|
AUROBINDO PHARMA LTD |
203145 |
001 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;80MG |
Prescription |
No |
No |
AB |
2013/04/19
|
MACLEODS PHARMS LTD |
206083 |
001 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;80MG |
Prescription |
No |
No |
AB |
2016/02/08
|
PRINSTON INC |
204382 |
001 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;80MG |
Prescription |
No |
No |
AB |
2023/08/11
|
AMNEAL PHARMS |
活性成分:HYDROCHLOROTHIAZIDE; VALSARTAN 剂型/给药途径:TABLET;ORAL 规格:12.5MG;160MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020818 |
002 |
NDA |
DIOVAN HCT |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;160MG |
Prescription |
Yes |
No |
AB |
1998/03/06
|
NOVARTIS |
078020 |
002 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;160MG |
Prescription |
No |
No |
AB |
2012/09/21
|
MYLAN PHARMS INC |
078946 |
004 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;160MG |
Prescription |
No |
No |
AB |
2013/03/21
|
LUPIN LTD |
201662 |
002 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;160MG |
Prescription |
No |
No |
AB |
2013/03/21
|
ALEMBIC |
202519 |
002 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;160MG |
Prescription |
No |
No |
AB |
2013/03/21
|
AUROBINDO PHARMA LTD |
203145 |
002 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;160MG |
Prescription |
No |
No |
AB |
2013/04/19
|
MACLEODS PHARMS LTD |
206083 |
002 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;160MG |
Prescription |
No |
No |
AB |
2016/02/08
|
PRINSTON INC |
204382 |
002 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;160MG |
Prescription |
No |
No |
AB |
2023/08/11
|
AMNEAL PHARMS |
活性成分:HYDROCHLOROTHIAZIDE; VALSARTAN 剂型/给药途径:TABLET;ORAL 规格:25MG;160MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020818 |
003 |
NDA |
DIOVAN HCT |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
25MG;160MG |
Prescription |
Yes |
No |
AB |
2002/01/17
|
NOVARTIS |
078020 |
003 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
25MG;160MG |
Prescription |
No |
No |
AB |
2012/09/21
|
MYLAN PHARMS INC |
078946 |
005 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
25MG;160MG |
Prescription |
No |
No |
AB |
2013/03/21
|
LUPIN LTD |
201662 |
004 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
25MG;160MG |
Prescription |
No |
No |
AB |
2013/03/21
|
ALEMBIC |
202519 |
004 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
25MG;160MG |
Prescription |
No |
No |
AB |
2013/03/21
|
AUROBINDO PHARMA LTD |
203145 |
004 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
25MG;160MG |
Prescription |
No |
No |
AB |
2013/04/19
|
MACLEODS PHARMS LTD |
206083 |
004 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
25MG;160MG |
Prescription |
No |
No |
AB |
2016/02/08
|
PRINSTON INC |
204382 |
003 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
25MG;160MG |
Prescription |
No |
No |
AB |
2023/08/11
|
AMNEAL PHARMS |
活性成分:HYDROCHLOROTHIAZIDE; VALSARTAN 剂型/给药途径:TABLET;ORAL 规格:12.5MG;320MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020818 |
004 |
NDA |
DIOVAN HCT |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;320MG |
Prescription |
Yes |
No |
AB |
2006/04/28
|
NOVARTIS |
078020 |
004 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;320MG |
Prescription |
No |
No |
AB |
2012/09/21
|
MYLAN PHARMS INC |
078946 |
001 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;320MG |
Prescription |
No |
No |
AB |
2013/03/21
|
LUPIN LTD |
201662 |
003 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;320MG |
Prescription |
No |
No |
AB |
2013/03/21
|
ALEMBIC |
202519 |
003 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;320MG |
Prescription |
No |
No |
AB |
2013/03/21
|
AUROBINDO PHARMA LTD |
203145 |
003 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;320MG |
Prescription |
No |
No |
AB |
2013/04/19
|
MACLEODS PHARMS LTD |
206083 |
003 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;320MG |
Prescription |
No |
No |
AB |
2016/02/08
|
PRINSTON INC |
204382 |
004 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
12.5MG;320MG |
Prescription |
No |
No |
AB |
2023/08/11
|
AMNEAL PHARMS |
活性成分:HYDROCHLOROTHIAZIDE; VALSARTAN 剂型/给药途径:TABLET;ORAL 规格:25MG;320MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020818 |
005 |
NDA |
DIOVAN HCT |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
25MG;320MG |
Prescription |
Yes |
Yes |
AB |
2006/04/28
|
NOVARTIS |
078020 |
005 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
25MG;320MG |
Prescription |
No |
No |
AB |
2012/09/21
|
MYLAN PHARMS INC |
078946 |
002 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
25MG;320MG |
Prescription |
No |
No |
AB |
2013/03/21
|
LUPIN LTD |
201662 |
005 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
25MG;320MG |
Prescription |
No |
No |
AB |
2013/03/21
|
ALEMBIC |
202519 |
005 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
25MG;320MG |
Prescription |
No |
No |
AB |
2013/03/21
|
AUROBINDO PHARMA LTD |
203145 |
005 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
25MG;320MG |
Prescription |
No |
No |
AB |
2013/04/19
|
MACLEODS PHARMS LTD |
206083 |
005 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
25MG;320MG |
Prescription |
No |
No |
AB |
2016/02/08
|
PRINSTON INC |
204382 |
005 |
ANDA |
VALSARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; VALSARTAN |
TABLET;ORAL |
25MG;320MG |
Prescription |
No |
No |
AB |
2023/08/11
|
AMNEAL PHARMS |